Switch to:
GuruFocus articles
Headlines from internet
Nov-20-17$15.57 (+5.99%)
11:27AMStraw Broke Mallinckrodts Back Seekingalpha
07:42AMValeant Bausch And Lomb 1 Contact Lenses China E Retailing Seekingalpha
04:47AMTracking Jeffrey Ubbens Valueact Portfolio Q3 2017 Update Seekingalpha
Nov-19-17
12:15PM4 Stocks Billionaire Bill Ackman Is Buying and Selling Fool
Nov-16-17$14.34 (-0.76%)
03:13PMValeant 2018 2025 Forecast Seekingalpha
10:00AMPrimer Define Fulfill Fiduciary Duty Care Seekingalpha
09:32AMValeant Look Positives Seekingalpha
03:56AMValeant Growth Seekingalpha
Nov-15-17$14.45 (+1.19%)
11:07AMValeant (VRX) Announces Pricing of Senior Secured Notes Zacks
06:00AMBear of the Day: Herbalife (HLF) Zacks
Nov-14-17$14.28 (-2.19%)
10:35PMIs Valeant Turning Things Around? Fool
07:39AMValeant Bull Thesis Unfolding Stock Worth 30 Plus Share Seekingalpha
Nov-13-17$14.6 (-5.07%)
03:32PMDaily Pharma Scoop Regenerons Appeal Good News Amgen Bristol Myers Sprycel Seekingalpha
03:07PMValeant Salix Growth Might Start Replace Asset Sales 2018 Seekingalpha
03:01PMValeant Strong Earnings Long Way Ahead Seekingalpha
02:34PMProfile: The @BMO $MCYBX fund sees a tasty opportunity in Valeant's short-dated high-yield bonds Barron's
10:53AMValeant Stock Tumbles on $750 Million Debt Offering Announcement theStreet
07:49AMValeant issues $750 million in debt to pay down debt MarketWatch
Nov-12-17
10:43AMWeek Review Chinas Creat Restructure 1_5 Billion Biotest Takeover Seekingalpha
10:43AMValeant Surges Post Q3 Reassessment Seekingalpha
07:11AMFinding Value Healthcare Sector Seekingalpha
Nov-11-17
03:15PM3 Biotech Stocks That Soared This Week: Are They Buys? Fool
Nov-10-17$15.38 (+0.2%)
02:21PMValeant Pharma: Why This Bear Still Growls Barron's
12:13PMWeekend roundup: Valeant’s earnings games | Tesla’s junk | How Apple stashes cash MarketWatch
Nov-09-17$15.35 (+3.16%)
02:04PMValeant (VRX) Earnings and Revenues Beat in Q3, Stock Up Zacks
12:05PMValeant is providing the media with an earnings metric that the SEC told it to stop using MarketWatch
11:52AMHealthcare: Is Valeant Pharmaceuticals the Turnaround Story of the Century? Fool
08:35AMSell Endo Earnings Seekingalpha
07:58AMValeant Pharmaceuticals (VRX) in Focus: Stock Moves 5.5% Higher Zacks
Nov-08-17$14.88 (+5.53%)
07:33PMHere's What Overshadowed Valeant Pharmaceuticals in October, Pushing Its Shares Down 18% Fool
03:44PMValeant 11 Months Later Countdown Continues Seekingalpha
01:17PMValeant Humble Crafty Deal Seekingalpha
12:50PMShort sellers are not evil, but they are misunderstood MarketWatch
09:36AMAllergan 25 Billion Reasons Investors Mad Seekingalpha
09:00AMIs the Worst Behind Valeant Pharmaceuticals' Stock? Fool
08:52AMCompany News For Nov 8, 2017 Zacks
06:02AMCase Broadcom Next Valeant Seekingalpha
05:20AMValeant Pharmaceuticals International Inc 2017 Q3 Results Earnings Call Slides Seekingalpha
Nov-07-17$14.1 (+17.11%)
08:00PMAckman Vows to Return to ADP; Valeant Rises After Asset Sale -ICYMI theStreet
04:30PMWhy Valeant Pharmaceuticals International, Denbury Resources, and Kindred Healthcare Jumped Today Fool
01:00PMWhy Valeant Pharmaceuticals International Stock Is Shooting Higher Today Fool
12:23PMValeant Vyzulta Approval Actually Big News Seekingalpha
12:13PMValeant's Explosive Gains Make the Stock Look Buyable Again theStreet
12:03PMValeant Pharmaceuticals Posts a Huge Third-Quarter Profit -- but There's a Catch Fool
09:54AMValeants White Knight Joseph Papa Seekingalpha
09:32AMU.S. stock market opens slightly higher as investors hunt for fresh catalyst MarketWatch
08:38AMAckman Fails in His Bid to Win Board Seats at ADP Bloomberg
07:44AMStock Futures Narrowly Mixed as Crude Oil Stabilizes After Surge theStreet
07:26AM5 telltale signs this stock market’s ‘euphoria’ could be ready to blow up MarketWatch
07:14AMValeant shares surge 12% after Q3 revenue beat MarketWatch
06:58AMValeant Sprout Let Seekingalpha
06:08AMGeneral Electric, Toyota and Snap - 5 Things You Must Know Before the Market Opens Tuesday theStreet
06:05AMU.S. stocks regroup for another bid on all-time highs MarketWatch
05:52AMWill Valeants 1 Billion Headache Metastasize Seekingalpha
Nov-06-17$12.04 (+4.79%)
02:34PMValeant: Fixing a Billion Dollar Mistake? Barron's
11:00AMValeant has officially given up its $1 billion bet on the ‘female Viagra’ MarketWatch
09:36AMValeant Divests Subsidiary Developing Female Libido Treatment theStreet
09:17AM2 Figures That'll Tell Us if Valeant Pharmaceuticals' Business Is Improving Fool
07:40AMGame Plan Week Cramers Mad Money 11 3 17 Seekingalpha
07:35AMValeant Gives Contentious Female Libido Pill Back to Old Owners Bloomberg
07:35AMValeant shares rise on divestiture of 'female Viagra' MarketWatch
07:32AMPharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah Zacks
Nov-05-17
07:04PMFutures Up After Lukewarm Jobs Report Friday theStreet
09:44AMSurprise Arrest of Saudi Billionaire Alwaleed Bin Talal Overshadows Big Earnings theStreet
Nov-03-17$11.49 (+3.89%)
07:08PMJobs Plus Earnings Equal Buys: Cramer's 'Mad Money' Recap theStreet
04:06PMApple Rally Sends Wall Street to Close at Records, Dow for Second Day in a Row theStreet
02:11PMDaily Pharma Scoop Timing Synergy Trade Valeants Vyzulta Approved Seattle Genetics Files Sbla Seekingalpha
12:24PMValeant Uceris Patent Loss Impair Salix Seekingalpha
11:45AMDow on Track for Record If Gains Hold as Apple Rallies on Earnings theStreet
10:47AMPDL BioPharma (PDLI) Q3 Earnings Beat, Revenues Rise Y/Y Zacks
09:49AMValeant Pharmaceuticals Stock Jumps on FDA Approval of Glaucoma Treatment theStreet
09:37AMStocks Rise as U.S. Adds 261,000 Jobs but Average Growth Is a Concern theStreet
09:00AMProgenics Pharmaceuticals Prospects Look Bright Seekingalpha
07:46AMStock Futures Rise After Apple's Beat and as Wall Street Awaits the Jobs Report theStreet
07:28AMThese suppliers are lining up to ride on Apple’s coattails MarketWatch
06:22AMValeant rallies 6.5% premarket after FDA approves Vyzulta drug MarketWatch
06:12AMDow aims for fresh record as stock futures climb ahead of U.S. jobs report MarketWatch
Nov-01-17$11.93 (+2.05%)
03:52PMValeant: Earnings, Debt Repayment, and What to Watch Next Week Barron's
10:41AMAckman Says Pershing Fund ‘Just Turned Positive’ for the Year Bloomberg
Oct-31-17$11.69 (+2.45%)
12:06PMAny Way You Slice It: Is Valeant a Safer Bet Following Debt Offering, Asset Sales? Barron's
Oct-30-17$11.41 (+0%)
03:08PMAny Way You Slice It: Is Valeant a Safer Bet Following Debt Offering, Asset Sales? Barron's
05:06AMWill Asset Impairments Finally Trip Valeant Seekingalpha
Oct-29-17
08:15AMA Me-Too Push By Biopharma Is Crowding the Psoriasis Market Fool
03:00AMCelgene Got Pummeled Seekingalpha
Oct-27-17$11.41 (-2.06%)
05:06AMSell these 5 scary stocks now MarketWatch
Oct-25-17$12.06 (-0.5%)
09:20AMValeant Pharmaceuticals Deep Dive Valuation Seekingalpha
Oct-24-17$12.12 (+0.58%)
11:38AMValeant Still Buy Seekingalpha
Oct-23-17$12.05 (-0.66%)
03:05PMMight Best Time Pick Aerie Pharmaceuticals 2017 Seekingalpha
03:03PMValeant Awash Cash Seekingalpha
12:01AMApple and Nike show that stock performance is linked to how CEOs spend money MarketWatch
Oct-20-17$12.13 (-2.8%)
07:43AMImplied Volatility Surging for Valeant Pharmaceuticals (VRX) Stock Options Zacks
Oct-19-17$12.48 (+0.73%)
04:29PMAckman: ADP Could Win Accounts By Buying Ceridian theStreet
08:00AMZacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Valeant Pharmaceuticals International, Teva Pharmaceuticals and Sanofi Zacks
12:18AMJ And J Unattractive Seekingalpha
Oct-18-17$12.39 (-3.28%)
03:59PMPricing Pressure, Competition Remain Headwinds for Pharma Stocks Zacks
03:58PMADP Chief Calls Ackman's Proxy Fight a Distraction From Plan Bloomberg
03:36AMAllergan Pharma Darling Faces Uncertainty Seekingalpha
Oct-13-17$13.39 (-3.18%)
02:01PMValeant Reports Positive Results on Psoriasis Drug Siliq Zacks
12:56PMWhy Valeant is Dropping? Barron's
Oct-11-17$14.29 (-1.18%)
06:33PMAckman's Chipotle, Valeant Failures Give ADP Holders Pause; NAFTA in Focus-ICYMI theStreet
11:31AMEarnings Preview Valeant Pharmaceuticals Seekingalpha
Oct-10-17$14.46 (+0.28%)
08:45PMAckman Tells ADP Retail Investors That Their Vote Matters theStreet
Oct-05-17$14.57 (+1.32%)
12:30PMTime Trust Gilead Seekingalpha
Oct-03-17$14.36 (-1.78%)
03:24PMInova Multiples Unimpressive Uncertainty Persists Valeant Seekingalpha
02:03PMValeant: Still Deep in Junk Territory Barron's
11:19AMValeant: Still Deep in Junk Territory Barron's
Oct-02-17$14.62 (+2.02%)
11:01AMValeant Paying Debts Seekingalpha
04:31AMValeant Warned Seekingalpha
Sep-29-17$14.33 (+4.14%)
01:01PMDebt Worries Dog Specialty Pharma Barron's
12:23PMValeant: Opportunity Time? Barron's
Sep-28-17$13.76 (-4.38%)
11:19AMWhy Valeant is Sinking Barron's
Sep-26-17$14.1 (+0.07%)
06:44AMCenturylinks Yield Red Flag Cramers Lightning Round 9 25 17 Seekingalpha
Sep-20-17$14.07 (+2.18%)
01:16PMLeft Citron Boy Cried Wolf Seekingalpha
Sep-19-17$13.77 (-0.15%)
09:05AMAccounting Adjustments Contribute Alpha Generation Seekingalpha
Sep-18-17$13.79 (-0.93%)
01:07PMTeva 1_1 Billion Asset Sale Much Ado Nothing Seekingalpha
Sep-12-17$14.43 (+1.69%)
01:45PMValeant Run Catalysts Seekingalpha
Sep-11-17$14.19 (+4.26%)
08:54AMCooper Companies Still Comes Valuation Seekingalpha
Sep-01-17$13.33 (-0.67%)
03:43PMValeant: A Clear Sell Seekingalpha
06:27AMStock Exchange: Biggest Cause Of Trading Failure Seekingalpha
Aug-29-17$13.24 (-6.96%)
04:42PMValeant: Headline Risk Vs. Fundamentals Seekingalpha
Aug-28-17$14.23 (+0.64%)
11:00AM3 Things You Need To Know As Valeant Gets Sued For $80 Billion Seekingalpha
Aug-25-17$14.14 (-4.14%)
07:38PMWhy Pershing Square's ADP Thesis Should Be Taken Seriously Seekingalpha
03:15PMValeant: The Long or Short of It Barron's
11:47AMLord, Abbett Sues Valeant; Claims $80 Billion In Losses Seekingalpha
Aug-23-17$14.42 (+0.49%)
12:06PMValeant Looks Good Post-Q2 Seekingalpha
Aug-18-17$14.39 (+0.35%)
03:42PMValeant Pharmaceuticals International, Inc. 2017 Q2 - Results - Earnings Call Slides Seekingalpha
12:36PMBiotech Forum Daily Digest: What's Next For Adamas Pharmaceuticals? Seekingalpha
Aug-17-17$14.34 (+1.34%)
07:39AMThe Market Is Much More Than Just Washington - Cramer's Mad Money (8/16/17) Seekingalpha
Aug-15-17$13.9 (+0.94%)
12:55PMProgenics: Dynavax 2.0? Seekingalpha
Aug-14-17$13.77 (-0.86%)
01:59PMWill Teva Pharmaceuticals Bottom This Time? Seekingalpha
Aug-11-17$13.89 (+0.58%)
11:59AMValeant: Three Steps to a Recovery? Barron's
11:35AMValeant: Earnings Expose Problem Seekingalpha
10:02AMMallinckrodt's Demise Will Not Be Orderly Seekingalpha
Aug-10-17$13.81 (-1.85%)
01:44PMACADIA Reports Strong Earnings Resulting From Accounting Change Seekingalpha
12:32PMValeant: There's No Denying It Seekingalpha
10:13AMThere's A Reason Valeant Pharmaceuticals Bulls Didn't Stay Convinced Seekingalpha
02:20AMValeant Pharmaceuticals: A Lesson In Value Traps Seekingalpha
12:18AMValeant: Much More Upside Remains, Despite Messy Quarter Seekingalpha
Aug-09-17$14.07 (-10.04%)
03:01PMValeant: A Plausible Path Forward? Barron's
12:05PMValeant, 9 Months Later: The Countdown Continues Seekingalpha
06:59AMValeant Bonds Rise on Early Debt Repayment Barron's
Aug-08-17$15.64 (+1.76%)
01:36PMIs Teva The Next Valeant? Seekingalpha
11:47AMIs Now The Time To Buy Valeant Pharmaceuticals? Seekingalpha
Aug-07-17$15.37 (+1.59%)
09:22AMMylan Has No Where to Go But Up, Possible as High as the $70's Next Year Seekingalpha
Aug-05-17
03:37AMWhy Corporate Spinoffs For Shire And Valeant Make Sense Seekingalpha
Aug-04-17$15.13 (-2.07%)
05:28PMReminder: The Shkreli Verdict In No Way Fixes Price Gouging Seekingalpha
Aug-02-17$16.42 (-1.97%)
03:48PMThis Could Be The End Of Valeant Seekingalpha
Aug-01-17$16.75 (+1.76%)
10:25AMTough Competition For Valeant's Newly Approved Drug, SILIQ Seekingalpha
08:35AMLaunch Of SILIQ Makes Valeant A Great Short Opportunity Seekingalpha
Jul-31-17$16.46 (-2.26%)
12:52PMWhy Valeant Doubled From Its Recent Lows, And Why It Might Double Again Seekingalpha
Jul-24-17$17.54 (+0.23%)
03:36PMQ2 Earnings Should Be The Catalyst For Valeant's Next Leg Higher Seekingalpha
11:20AMFragile Vs. Antifragile: You Have To Understand What You're Dealing With First Seekingalpha
Jul-20-17$17.6 (+2.03%)
05:02PMMannKind - Afrezza Television Ad Debuts - What Investors Need To Know Seekingalpha
07:55AMHunting And Profiting From 'Fat Tails' - Be Long HighVol Assets Seekingalpha
Jul-19-17$17.25 (+0.52%)
08:28AMValeant Pharmaceuticals: Becoming A Better Buy? Seekingalpha
Jul-18-17$17.16 (-1.21%)
09:34AMJohnson & Johnson's Tremfya: A Potential Blockbuster Drug Seekingalpha
08:58AMEarnings Preview: Valeant Pharmaceuticals Seekingalpha
08:45AMThe Cooper Companies: $250 Looks Stretched Seekingalpha
Jul-17-17$17.37 (+0.75%)
04:57PMValeant: At Worst, A Good Catalyst Play Seekingalpha
03:38PMThe Good And Bad About The Obagi Sale Seekingalpha
03:00PMJohnson & Johnson: Approval Of TREMFYA Is Huge Win For Shareholders Seekingalpha
11:59AMBiotech Forum Daily Digest: Why Progenics Could Rally This Summer Seekingalpha
Jul-14-17$17.24 (-0.29%)
11:54AMValeant Pharmaceuticals Is Likely To Beat Earnings Seekingalpha
Jul-13-17$17.29 (+1.77%)
12:12PMValeant: Much More Upside Remains Part II Seekingalpha
Jul-12-17$16.99 (+2.53%)
02:01PMValeant: Much More Upside Remains Seekingalpha
Jul-11-17$16.57 (-0.54%)
01:33PMValeant Pharmaceuticals: Initiating Coverage With Buy Rating And Price Target = $32 Seekingalpha
Jul-07-17$16.23 (-2.23%)
12:45PMValeant: Why JPMorgan Is Asking Fundamentally The Wrong Question Seekingalpha
Jul-03-17$16.97 (-1.91%)
09:22AMValeant Has More Time, And Flexibility, Than You Might Think Seekingalpha
Jul-02-17
12:30AMValeant Has Topped Out For Now: A Simple Analysis Seekingalpha
Jun-30-17$17.3 (-0.06%)
11:06AM#Valeant After Ackman: Paulson Logs 26% Gain Barron's
Jun-27-17$16.65 (-2.52%)
12:42PMCAR-T Value Calculation In The Firing Line Seekingalpha
Jun-20-17$13.15 (-2.38%)
05:01PMValeant: Let's Talk Pipeline And Value Seekingalpha
01:16PMValeant: Is This Time Different? Seekingalpha
12:54PMYes, #Valeant is Rising But… Barron's
Jun-19-17$13.47 (+6.4%)
12:14PMCan John Paulson Revive #Valeant? Barron's
May-16-17$14.08 (-0.64%)
12:13PM3 Things In Biotech You Should Learn Today: May 16, 2017 Seekingalpha
12:13AMValeant: Overbought And Overvalued Seekingalpha
May-15-17$14.17 (+4.27%)
10:46AMValeant's Q1 - Key Bullish And Bearish Takeaways Seekingalpha
09:09AM5 More Reasons Valeant Pharmaceuticals Bottomed Seekingalpha
May-12-17$13.59 (-1.52%)
08:53AMValeant: More Debt Than Enterprise Value Seekingalpha
May-11-17$13.8 (+8.83%)
03:57PM#Valeant: ‘Hold the Applause,’ says Gimme Credit Barron's
12:29PMValeant Pharmaceuticals: Feeling Sentimental? Barron's
10:26AMValeant: 6 Months Later Seekingalpha
May-10-17$12.68 (+5.23%)
04:21PMThe Crux Of Valeant Pharmaceuticals' First Quarter In 4 Pictures Seekingalpha
01:51PMValeant: The Market Has Spoken Seekingalpha
12:26PMValeant's Story Is Changing Seekingalpha
12:16AMValeant: One-Time Tax Benefit = Better Earnings Optic Seekingalpha
May-09-17$12.05 (+24.1%)
04:44PMTouring The Top Market News Seekingalpha
08:45AMValeant Pharmaceuticals International, Inc. 2017 Q1 - Results - Earnings Call Slides Seekingalpha
12:13AMValeant Can Beat Earnings Seekingalpha
May-08-17$9.71 (-3.57%)
11:02PMValeant: Huge Legal Risk Seekingalpha
May-07-17
04:34PMValeant: Disappointing Earnings? Seekingalpha
May-06-17
03:43PMEarnings Preview: Valeant Pharmaceuticals Seekingalpha


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK